Need a specific person's email?
Browse BioCorRx Pharmaceuticals Inc a subsidiary of BioCorRx Inc (OTC: BICX)'s employee directory (about 2 employees) and reveal verified emails free.
BioCorRx Pharmaceuticals Inc a subsidiary of BioCorRx Inc (OTC: BICX)'s most common email format is First@biocorrx.com (ex. John@biocorrx.com), used for 64% of biocorrx.com addresses. BioCorRx Pharmaceuticals Inc a subsidiary of BioCorRx Inc (OTC: BICX) uses 4 email patterns.
| Format | Example | Share of biocorrx.com |
|---|---|---|
| First@biocorrx.comMost common | John@biocorrx.com | |
| Last@biocorrx.com | Doe@biocorrx.com | |
| FL@biocorrx.com | JD@biocorrx.com | |
| LF@biocorrx.com | DJ@biocorrx.com |
Browse BioCorRx Pharmaceuticals Inc a subsidiary of BioCorRx Inc (OTC: BICX)'s employee directory (about 2 employees) and reveal verified emails free.
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
BioCorRx Pharmaceuticals Inc., a subsidiary of BioCorRx Inc., operates in the pharmaceutical manufacturing sector with a focus on addiction-related conditions. It is a clinical-stage and commercial biopharmaceutical company developing treatments for opioid use disorder and alcohol use disorder to support long-term recovery and wellness. Its lead candidate, BICX104, is an implantable, sustained-release naltrexone formulation designed to improve patient adherence and reduce relapse risk as it advances toward potential FDA approval. The company is based in Anaheim, California, and operates with a small team. In 2025, BioCorRx expanded its portfolio by entering into a definitive agreement to acquire LUCEMYRA, an FDA-approved medication for opioid withdrawal, signaling a broader product offering.
Most common format
First@biocorrx.com
Example: John@biocorrx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.